Kiran Mazumdar Shaw, founder of Biocon Limited, has stepped down as the Director of the Company, with effect from the conclusion of the 25th Annual General Meeting that was held on August 1, 2024. This is in view of the fact that her second and last tenure as an Independent Director would be concluding on September 03, 2024.
Consequently, she shall also cease to be Chairperson or Member of Nomination & Remuneration Committee, and a Member of the Corporate Social Responsibility/ Environment, Social & Governance Committee of the Board of the Company.
Shaw is the Chairperson and Managing Director of Biocon, Asia’s bio-pharmaceuticals enterprise. Named among TIME magazine’s 100 most influential people in the world, she is recognized as a global thought leader for Biotechnology.
Under her stewardship, Biocon has evolved since its inception in 1978 from an industrial enzymes company to a fully-integrated, innovation-led, emerging global biopharmaceutical enterprise committed to reduce therapy costs of chronic conditions like diabetes, cancer and autoimmune diseases.
As a global influencer, she is ranked among ‘World’s 25 Most Influential People in Biopharma’ by Fierce Biotech, Forbes magazine’s ‘World’s 100 Most Powerful Women’ and Fortune’s ‘Top 25 Most Powerful Women in Asia-Pacific.’
She has been recognized as the only Indian on Forbes’ list of ‘World’s Self-Made Women Billionaires.’ She has been featured in ‘The Worldview 100 List’ of the most influential visionaries by Scientific American magazine and named among the ‘100 Leading Global Thinkers’ by Foreign Policy magazine.
She has ranked No. 1 in the Business Captains category on ‘Medicine Maker Power List’ 2018, an index of the 100 most influential people across the globe in the field of medicine, where she has been among the Top 10, consecutively since 2015. Most recently, she is elected as a full-term member of the Board of Trustees of The MIT Corporation, USA.
She has been recognised with the Padma Shri in 1989 and the Padma Bhushan in 2005.